An updated perspective and pooled analysis of cardiovascular outcome trials of GLP-1 receptor agonists and SGLT-2 inhibitors
Guardado en:
Autores principales: | Mustafa Kılıçkap, Meral Kayıkçıoğlu, Lale Tokgözoğlu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
KARE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1ec5f61f525d404f917bf8a4266a0e4c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
GLP-1, SGLT-2, new devices for interventional cardiologists
por: Çetin Erol
Publicado: (2021) -
Assessment of awareness of risk factors and heart healthy lifestyle as a part of routine cardiovascular evaluation in secondary prevention
por: Meral Kayıkçıoğlu
Publicado: (2021) -
Systematic review and meta-analysis for prevention of cardiovascular complications using GLP-1 receptor agonists and SGLT-2 inhibitors in obese diabetic patients
por: Kazushi Uneda, et al.
Publicado: (2021) -
Effects of SGLT-2 inhibitor on myocardial fibrosis and left ventricular reverse remodeling
por: Dipak Katare, et al.
Publicado: (2021) -
Cardiovascular outcomes after initiating GLP-1 receptor agonist or basal insulin for the routine treatment of type 2 diabetes: a region-wide retrospective study
por: Enrico Longato, et al.
Publicado: (2021)